Search
Aclaris Therapeutics Inc
ACRSAdd to Watchlist
5.560USD
+0.220+4.12%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
776.53MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2018
By BusinessUSD
Name
Revenue
Proportion
Licensing
5.95M
76.08%
Laboratory Research Revenue
1.87M
23.92%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Licensing
5.95M
76.08%
Laboratory Research Revenue
1.87M
23.92%